XT Series Cabinets, IV Compounding Technology and Analytics Solutions Featured in Stand 49
March 22, 2017
MOUNTAIN VIEW, Calif.
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems and pharmacies, today announced it will showcase its XT Automated Dispensing Cabinets, IV solutions and drug diversion analytics software at the European Association of Hospital Pharmacists (EAHP) Congress from March 22-24 in Cannes, France. Together, these solutions help support safer and more streamlined medication distribution in hospitals.
Omnicell® XT Automated Dispensing Cabinets are designed with new hardware features that improve workflow for nurses—allowing them more time for patient-centered activities while helping to increase safety and accuracy in medication dispensing. The scalability of the XT system is responsive to a growing health system, and the new technology is designed to easily adapt to future innovations. Omnicell’s automated dispensing cabinets have been awarded the highest ranking from KLAS for 11 years in a row.
In addition to Omnicell’s automated medication dispensing cabinets, the following solutions will be displayed in Stand 49:
• i.v.STATION™, which prepares and dispenses ready-to-administer, sterile compounded medications
• i.v.SOFT® Assist, an all-in-one IV workflow solution for both hazardous and non-hazardous compounding
• Omnicell Analytics, a web-based diversion analytics tool for detecting potential drug diversion within a health system
• Anywhere RN™, an application that allows nurses to access automated dispensing cabinets from virtually any hospital workstation
“We’re excited to introduce Omnicell’s comprehensive set of solutions to the attendees at EAHP and demonstrate how our innovations, including our new XT cabinets, are making a significant impact in the way hospitals operate,” said Arthur Van Dongen, general manager, International at Omnicell. “The theme for this year’s conference is ‘Hospital pharmacists – catalysts for change,’ and we feel that pharmacists can achieve substantial and quantifiable change by implementing this latest technology.”